Navegando por Palavras-chave "Drug Prescriptions"
Agora exibindo 1 - 5 de 5
Resultados por página
Opções de Ordenação
- ItemAcesso aberto (Open Access)Characterization of drugs prescribed to the elderly in the Family Health Strategy(Cadernos Saude Publica, 2009-05-01) Paes de Oliveira, Camila Alves; Sanches Marin, Maria Jose [UNIFESP]; Marchioli, Milton; Magalhaes Pizoletto, Bruno Henrique; Santos, Rafael Varella dos; Fac Med Marilia; Universidade Federal de São Paulo (UNIFESP)Considering that the elderly are heavy consumers of medications, with significant consequences for their living conditions, the current study was intended to analyze the characteristics of such drug prescription, using the indicators proposed by the World Health Organization (WHO), and to characterize the drug classes prescribed to them in four units under the Family Health Strategy (FHS) in Marilia, Sao Paulo State, Brazil. One family health unit (FIIU) was selected by region of the city, and 100 patient charts were checked in FHU-A; 86 in B, 99 in C, and 97 in D. According to WHO drug prescription criteria, the results were similar to the recommended patterns except for drug prescription by generic name. In addition, there were significant differences between the family health units. The most frequently prescribed drug classes were for cardiovascular disorders. The health professionals showed a concern for adjusting drug prescription to rational-use criteria. However, there is a need for understanding the differences in prescription between units and a search for consensus, aimed at rational drug use.
- ItemAcesso aberto (Open Access)Evaluation of drug prescription quality indicators in a primary care unit with different models of healthcare(Ministerio Da Saude, 2016) de Melo, Daniela Oliveira [UNIFESP]; Ansaldi da Silva, Silvia Regina; Cardozo de Castro, Lia LusitanaObjective: to describe drug prescription indicators in a primary care unit with different models of health care. Methods: this was a descriptive study using secondary data of prescriptions with regard to quality indicators in a health facility that has three health care models: Outpatient Medical Care (OMC), Primary Health Unit (PHU) and Family Health Strategy (FHS) in Vila Nova Jaguar OMC/PHU in Sao Paulo-SP, Brazil, from July to October 2011. Results: 16,720 prescriptions were studied; the proportion of drugs provided through the Municipal Essential Medication List was higher for FHS prescriptions (98.9%), compared to PHU (95.6%) and OMC (95.7%); similarly, both the use of the generic name of the drugs and the proportion of drugs provided was higher among ESF prescriptions (98.9% and 96.1%, respectively), compared with PHU (94.4 % and 92.9%) and OMC (94.0% and 92.7 %). Conclusion: all the prescription indicators show better results for FHS.
- ItemAcesso aberto (Open Access)Prescrição de terapias baseadas em evidências para pacientes de alto risco cardiovascular: estudo REACT(Sociedade Brasileira de Cardiologia - SBC, 2013-03-01) Berwanger, Otávio [UNIFESP]; Mattos, Luiz Alberto Piva e; Martin, José Fernando Vilela; Lopes, Renato Delascio [UNIFESP]; Figueiredo, Estevão Lanna; Magnoni, Daniel; Precoma, Dalton Bertolim; Machado, Carlos Alberto; Guimarães, Jorge Ilha; Andrade, Jadelson Pinheiro de; Hospital do Coração; Sociedade Brasileira de Cardiologia; Instituto Dante Pazzanese de Cardiologia; Rede D'Or Unidades de Hemodinâmica e Intervenção Cardiovascular; Hospital de Base; Universidade Federal de São Paulo (UNIFESP); Hospital Lifecenter; Sociedade Hospitalar Angelina Caron; Ambulatório Médico de Especialidades Maria Zélia; Hospital da BahiaBACKGROUND: Data on outpatient care provided to patients at high cardiovascular risk in Brazil are insufficient. OBJECTIVE: To describe the profile and document the clinical practice of outpatient care in patients at high cardiovascular risk in Brazil, regarding the prescription of evidence-based therapies. METHODS: Prospective registry that documented the ambulatory clinical practice in individuals at high cardiovascular risk, which was defined as the presence of the following factors: coronary artery disease, cerebrovascular and peripheral vascular diseases, diabetes, or those with at least three of the following factors: hypertension, smoking, dyslipidemia, age > 70 years, family history of coronary artery disease, chronic kidney disease or asymptomatic carotid artery disease. Basal characteristics were assessed and the rate of prescription of pharmacological and non-pharmacological interventions was analyzed. RESULTS: A total of 2364 consecutive patients were included, of which 52.2% were males, with a mean age of 66.0 years (± 10.1). Of these, 78.3% used antiplatelet agents, 77.0% used statins and of patients with a history of myocardial infarction, 58.0% received beta-blockers. Concomitant use of these three classes of drugs was 34%; 50.9% of hypertensive, 67% of diabetic and 25.7% of dyslipidemic patients did not achieve the goals recommended by guidelines. The main predictors of prescription therapies with proven benefit were centers with a cardiologist and history of coronary artery disease. CONCLUSION: This national and representative registry identified important gaps in the incorporation of therapies with proven benefit, offering a realistic outlook of patients at high cardiovascular risk.
- ItemAcesso aberto (Open Access)Prescription errors in Brazilian hospitals: a multi-centre exploratory survey(Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, 2009-02-01) Miasso, Adriana Inocenti; Oliveira, Regina Célia de; Silva, Ana Elisa Bauer de Camargo; Lyra Junior, Divaldo Pereira de; Gimenes, Fernanda Raphael Escobar; Fakih, Flávio Trevisan [UNIFESP]; Cassiani, Sílvia Helena de Bortoli; Universidade de São Paulo (USP); Universidade de Pernambuco Faculdade de Enfermagem Nossa Senhora das Graças; Universidade Federal de Goiás Faculdade de Enfermagem; Universidade Federal de Sergipe Faculdade de Farmácia; Universidade Camilo Castelo Branco; Universidade Federal de São Paulo (UNIFESP)In Brazil, millions of prescriptions do not follow the legal requirements necessary to guarantee the correct dispensing and administration of medication. This multi-centre exploratory study aimed to analyze the appropriateness of prescriptions at four Brazilian hospitals and to identify possible errors caused by inadequacies. The sample consisted of 864 prescriptions obtained at hospital medical clinics in January 2003. Data was collected by three nurse researchers during one week using a standard data sheet that included items about: the type of prescription; legibility; completeness; use of abbreviations; existence of changes and erasures. There were statistically significant differences between incomplete electronic prescriptions at hospital A, and handwritten ones from hospitals C (Ç2 = 12.703 and p < 0.001) and D (Ç2 = 14.074 and p < 0.001). Abbreviations were used in more than 80% of prescriptions at hospitals B, C and D. Changes were found in prescriptions at all hospitals, with higher levels at hospitals B (35.2%) and A (25.3%). This study identified a range of vulnerable points in the prescription phase of the medication system at the hospitals. Physicians, pharmacists and nurses should therefore jointly propose strategies to avoid these prescription errors.
- ItemAcesso aberto (Open Access)Proposta sobre uso de dados de receitas de antimicrobianos retidas: a experiência EUREQA(Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, 2012-05-01) Camargo, Eduardo Celso Gerbi; Kiffer, Carlos Roberto Veiga [UNIFESP]; Pignatari, Antonio Carlos Campos [UNIFESP]; Shimakura, Silvia Emiko; Ribeiro Jr, Paulo Justiniano; Monteiro, Antonio Miguel Vieira; Instituto Nacional de Pesquisas Espaciais; Universidade Federal de São Paulo (UNIFESP); Universidade Federal do Paraná Laboratório de Estatística e GeoinformaçãoThis study demonstrates that the use of information from medical prescriptions is essential for understanding the dynamics of community bacterial resistance. The resulting analysis can also influence and help establish more adequate public health policies on the control and optimization of antimicrobial use. The article demonstrates the use of a logical model developed by the EUREQA project for acquisition, classification, interpretation, and analysis of data from prescriptions for oral antimicrobial use.